Related content

Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 162-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systems Pharmacology for Drug Discovery and Development: Paradigm Shift or Flash in the Pan?

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 5, 2013-05 ,pp. : 379-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 247-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of a mother–child database for drug exposure and adverse event detection in the Military Health System

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 5, 2015-05 ,pp. : 510-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Development and Demise of a Cataract Surgery Database

By Lum Flora   Schachat Andrew P.   Jampel Henry D.  

Joint Commission Journal on Quality and Patient Safety, Vol. 28, Iss. 3, 2002-03 ,pp. : 108-114

Joint Commission Resources

Access to resources Recommend Favorite